Skip to main content
. Author manuscript; available in PMC: 2014 Aug 15.
Published in final edited form as: Nature. 2013 Oct 30;503(7475):277–280. doi: 10.1038/nature12746

Table 1.

SHIVAD8 infected macaques treated with anti-HIV mAbs

Animal Pre-Infection Treatment Initiation Pre mAb Treatment Clinical Status mAb Administered
CD4+ T Cells
(Cells/µl)		 Weeks Post Infection CD4+ T Cells
(Cells/µl)		 Viral Load
(RNA Copies/ml)		 3BNC117
(mg/kg)		 10-1074
(mg/kg)
KZ6 881 12 1447 5.22E+03 Post-Acute Set Point 10 0
MB6 545 12 1598 7.43E+03 Post-Acute Set Point 10 0
MB8 1512 12 2625 1.14E+04 Post-Acute Set Point 0 10
MCN 210 12 599 2.14E+04 Post-Acute Set Point 0 10
DBZ3 650 159 118 1.08E-04 Asymptomatic 10 10
DC99A 623 159 165 7.60E+03 Asymptomatic 10 10
DBXE 1585 163 158 1.96E+05 Intermittent diarrhea 10 10
DCF1 1203 157 105 1.44E+05 Intermittent diarrhea 10 10
DCM8 608 163 43 1.59E+0. Intermittent diarrhea 10 10